Currently, we have yet to find methods to prevent type 1 diabetes. Therefore, any relevant information that may play a role in diabetes prevention or occurrence is of particular interest to families affected by the condition. A paper entitled “Mode of Obstetrical Delivery and Type 1 Diabetes: A Sibling Design Study” (... Read more
Summer is a very exciting time for many young adults with diabetes. Many are transitioning to college and beginning a new chapter in their lives. Moving into a college environment can be stressful for all students, let alone for those with chronic illnesses, such as diabetes. During a recent clinic visit, one of my college-bound patients... Read more
As is my usual practice, many of my ideas for blogs originate with my experiences with patients and families. Using analogies in clinical practice in order to make concepts more understandable is an excellent means to reach an “aha” moment. Oftentimes, we, as clinicians, provide very comprehensive explanations as to why certain... Read more
AFREZZA® has been approved by the FDA (Food and Drug Administration) for use in adults. What is AFREZZA?
AFREZZA is an “ultra rapid- acting mealtime insulin” that has been developed for adults with type 1 and 2 diabetes to improve glycemic control. The system includes an inhaler device that consists of AFREZZA inhalation powder... Read more
I have received a number of excited notifications from patients this past week in regard to the bionic pancreas. As such, I did my due diligence to research this new device and noted the recent scholarly paper published by Russell, El-Khatib, Sinha, Magyar, MecKeon, Goergen, Balliro, Hilliard, Nathan, and Damiano in The New England Journal... Read more